Why Xero’s $80 Share Price Is Back in the Spotlight Before Results

Why Xero’s $80 Share Price Is Back in the Spotlight Before Results

May 3, 2026

SYDNEY, May 4, 2026, 04:03 AEST

Xero Limited is seeking approval to list 7,857 new ordinary shares on the ASX, following the conversion of employee restricted stock units—a standard move, coming less than two weeks out from the cloud-accounting company’s full-year results. According to a May 1 filing, the shares were split across two allotments: 94 issued on March 26, with the remaining 7,763 on March 31. This brings Xero’s total ordinary shares on issue to 170,599,259.

The filing barely registers—it’s under 0.01% of Xero’s total ordinary shares. Still, it brings fresh attention to the company’s share count and employee equity awards ahead of May 14, the date set for Xero’s FY26 results covering the year to March 31. Restricted stock units, or RSUs, give employees the chance to receive shares if certain criteria are met.

As of the dateline, the ASX cash market had yet to open—usual hours stretch from roughly 09:59:45 through to 16:00 Sydney time. Xero shares closed out May 1 at A$80.57, a 0.66% gain for the session; Google Finance puts the stock’s 52-week high at A$196.52.

But guidance is turning out to be the sticking point. Back in February, Xero flagged it would switch to adjusted EBITDA guidance with its FY26 results—plus, it promised a one-time range for FY27 revenue growth. Adjusted EBITDA strips out interest, tax, depreciation, and amortisation, along with some company-specific tweaks; investors lean on this to assess software profitability, minus non-cash and one-off charges.

Six months in, Xero logged a 20% jump in H1 FY26 operating revenue, reaching NZ$1.194 billion. Adjusted EBITDA landed at NZ$350.9 million; free cash flow wasn’t far behind, coming in at NZ$321.1 million. The company posted a “Rule of 40” score at 44.5%—that’s the sum of revenue growth and margin, a key software metric. Open Briefing

Subscriber numbers climbed 10% to hit 4.59 million for the half, with average revenue per user also jumping 15% to $49.63. The focus for Xero isn’t just landing fresh accounting clients—it’s getting more products into the hands of its existing base.

The U.S. poses a tougher challenge. Last June, Reuters said Xero struck a deal to acquire U.S.-Israeli payments firm Melio for as much as $3 billion—an attempt to plug payments into its accounting platform and gain ground in a country still only delivering about 7% of its sales. RBC Capital Markets’ Garry Sherriff called the move “much to like” at the time. E&P’s Paul Mason, though, said the price tag looked “pretty full,” unless cost synergies actually materialized. Reuters

Rivals are already moving. Intuit, which owns QuickBooks, inked a multi-year agreement topping $100 million with OpenAI, according to Reuters in November. The deal brings AI agents into both QuickBooks and TurboTax. That puts extra pressure on Xero as it ramps up its own small-business AI push.

But the risks are front and center: Melio integration might drag, U.S. payment adoption could fall short, or ramped-up AI investment may squeeze margins before any growth shows up. The limited stock issuance barely registers. The bigger concern? Whether Xero stays disciplined with cash as it leans harder into the U.S. payments push.

On May 14, Xero faces a real test: can its core accounting platform, Melio payments, and AI features finally start working together? Investors, pricing shares at A$80, have already priced in plenty. They’re still waiting for clearer evidence.

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • ASX Morning Feed: Top Movers, Biotech and Energy Updates
    June 23, 2026, 9:46 PM EDT. Australian Securities Exchange (ASX) small-cap stocks moved sharply with Tlou Energy up 50%, Avecho Biotech gaining 47%, and Unity Metals rising 46%. Avecho's Phase III insomnia trial passed an interim safety review, accelerating recruitment for 519 participants. Prominence Energy confirmed widespread helium, hydrogen, and methane anomalies at its Eyre Project through satellite studies, supporting future drilling plans. On the downside, Redstone Resources fell 25%, Alliance Nickel dropped 19%, and Megado Minerals fell 18%. Adavale Resources reported gold assays up to 10.3g/t in drilling, Atomic Eagle secured environmental and indigenous approvals for its Zambian uranium project, while Azzuro and Everest Metals disclosed promising exploration progress. The Calmer Co advances US retail expansion with Coles acceptance of its products. Market participants are focused on resource development and clinical trial progress across key small-cap sectors.